|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2025 | A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer | VOLDERS, Pieter-Jan; Aftimos, Philippe; Dedeurwaerdere, Franceska; Martens, Geert; Canon, Jean-Luc; Beniuga, Gabriela; Van Huysse, Jacques; FROYEN, Guy; De Pauw, Rebecca; Prenen, Hans; Lambin, Suzan; Decoster, Lore; Vaeyens, Freya; Rottey, Sylvie; Van Dam, Pieter-Jan; Decoster, Lynn; Rutten, Annemie; Schreuer, Max; Loontiens, Siebe; van der Meulen, Joni; MEBIS, Jeroen; CUPPENS, Kristof; Tejpar, Sabine; Vanden Bempt, Isabelle; De Greve, Jacques; Schroeder, David; van Marcke, Cedric; van den Bulcke, Marc; de Azambuja, Evandro; Punie, Kevin; MAES, Brigitte | Journal Contribution | A1 |
| 2 | 2024 | Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity | HAESEN, Sibren; JAGER, Manon Marie; Brillouet, Aline; DE LAAT, Iris; VASTMANS, Lotte; VERGHOTE, Eline; DELAET, Anouck; D'HAESE, Sarah; HAMAD, Ibrahim; KLEINEWIETFELD, Markus; MEBIS, Jeroen; MULLENS, Wilfried; LAMBRICHTS, Ivo; WOLFS, Esther; DELUYKER, Dorien; BITO, Virginie | Journal Contribution | A1 |
| 3 | 2024 | Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review | CLAES, Marithe; Tuts, L.; ROBIJNS, Jolien; Mulders, K.; van de Werf, E.; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 4 | 2023 | The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Pierson, Maud; Lenaerts, Melissa; MEBIS, Jeroen | Journal Contribution | A1 |
| 5 | 2023 | Steroid-dependent pericarditis following anti-PD1 immunotherapy in a metastatic melanoma patient: a case report | Verhaert, Marthe; MEBIS, Jeroen; Aspeslagh, Sandrine; von Kemp, Berlinde; Rossi, Valentina; Komorovsky, Roman; Gambaro, Alessia; Kovacs, Boldizsar; Peverelli, Marta; Jathanna, Nikesh | Journal Contribution | A1 |
| 6 | 2023 | A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial | ROBIJNS, Jolien; Van Bever, Leen; Hermans, Sanne; CLAES, Marithe; LODEWIJCKX, Joy; Lenaerts, Melissa; Tuts, Laura; Vandaele, Eline; Vinken, Evelien; Noé, Leen; Verboven, Katleen; MAES, Annelies; Van de Velde, Anne-Sophie; BULENS, Paul; Bulens, Philippe; Van den Bergh, Laura; MEBIS, Jeroen | Journal Contribution | A1 |
| 7 | 2023 | Photobiomodulation in the management of chemotherapy-induced peripheral neuropathy: a randomized, controlled trial | CLAES, Marithe; LODEWIJCKX, Joy; Hermans, S.; Peeters, P.; MEBIS, Jeroen; ROBIJNS, Jolien | Journal Contribution | M |
| 8 | 2023 | Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study | Joris, S. R.; Denys, H.; Collignon, J. J.; Rasschaert, M.; de Roodenbeke, D. T'Kint; Duhoux, F. P.; Canon, J-L.; Tejpar, S.; MEBIS, Jeroen; Decoster, L.; Aftimos, P. G.; De Greve, J. | Journal Contribution | M |
| 9 | 2023 | GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative | Aftimos, P. G.; Punie, K.; Decoster, L.; de Lummen, C. Van Marcke; Hebrant, A.; Raicevic, G.; Van Valckenborgh, E.; MAES, Brigitte; Maetens, J.; Collignon, J. J.; van den Mooter, T. F. A.; Fried-Vermeij, J.; Demey, W.; Tejpar, S.; Peeters, M.; Canon, J-L.; Lybaert, W.; MEBIS, Jeroen; Rottey, S.; De Greve, J. | Journal Contribution | M |
| 10 | 2023 | Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study | Decoster, L.; Aftimos, P. G.; Rottey, S.; Prenen, H.; Collignon, J. J.; MEBIS, Jeroen; Canon, J-L.; Fastenaekels, V.; Cappoen, N.; Joris, S. R.; De Greve, J. | Journal Contribution | M |
| 11 | 2022 | Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group | Vergote, I; Van Nieuwenhuysen, E; De Waele, S; Vulsteke, C; Lamot, C; Van den Bulck, H; CLAES, Nele; Graas, MP; DEBROCK, Guy; Spoormans, I; Vuylsteke, P; Honhon, B; Verhoeven, D; Daan De Maeseneer; Dirix, L; MEBIS, Jeroen; Vroman, P; Denys, H; Mena, CM; Pelgrims, G; Van Steenberghe, M; van Gorp, T; Gennigens, C | Journal Contribution | A1 |
| 12 | 2022 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole‐breast irradiation (LABRA trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Puts, Sofie; Timmermans, An; Noe, Leen; Vanmechelen, Sofie; Govers, Mieke; Van de Werf, Evelyn; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen; Claes, Stefan; Pannekoeke, Luc | Journal Contribution | A1 |
| 13 | 2022 | Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; MEBIS, Jeroen | Journal Contribution | M |
| 14 | 2022 | Response to the Comment on ‘‘Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)” by He et al. | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes , Stefan; Van Bever, Leen; Pannekoeke , Luc; Censabella, Sandrine; Busse, Lore; COLSON, Dora; Kaminski, Iris; Broux, Victoria; Puts , Sofie; Vanmechelen, Sofie; Timmermans, An; Noe, Leen; BULENS, Paul; Govers, Mieke; Maes, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 15 | 2021 | A digital automated health monitoring system for oncology patients during the COVID-19 pandemic: Practical issues and lessons for the future | ROBIJNS, Jolien; LODEWIJCKX, Joy; WIJNEN, Katrien; Snoekx, Sylvana; Hilkens, Ruth; Bortels, Sandra; Lenders, Hilde; Nassen, Wendy; Dewaele, Elien; Luyten, D.; Joosens, Eric; Requilé, Annelies; Verheezen, Yolanda; Wessels, Tim; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 16 | 2021 | Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study | Joris, S.; Denys, H.; Martin, M.; de Roodenbeke, D. t'Kint; Duhoux, F.; Berchem, G.; Punie, K.; Bols, A.; MEBIS, Jeroen; Canon, J-L.; Decoster, L.; De Greve, J. | Journal Contribution | M |
| 17 | 2021 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 18 | 2020 | A Narrative Review on the Use of Photobiomodulation Therapy for the Prevention and Management of Acute Radiodermatitis: Proposed Mechanisms, Current Clinical Outcomes, and Preliminary Guidance for Clinical Studies | ROBIJNS, Jolien; LODEWIJCKX, Joy; Bensadoun, Rene-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 19 | 2020 | Photobiomodulation Therapy for the Management of Chemotherapy-Induced Peripheral Neuropathy: An Overview | LODEWIJCKX, Joy; ROBIJNS, Jolien; Bensadoun, René-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 20 | 2019 | Quality of life, fatigue, and subjective cognitive functioning immediately and 6 months after adjuvant chemotherapy in breast cancer patients | MEBIS, Jeroen; Censabella, S; Engels, Sofie; Van Marsenille, C.; ORYE, Guy; MARQUETTE, Sophie; Vansteelant, L.; Luyten, D.; MAES, Annelies; Noé, L; BULENS, Paul | Journal Contribution | M |
Loading...
5
0
5
0
false